Parnell Pharmaceuticals Holdings Ltd
PARNF · OTC
12/31/2016 | 9/30/2016 | 6/30/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $7 | $2 | $4 | $6 |
| + Debt | $30 | $17 | $20 | $17 |
| Enterprise Value | $23 | $15 | $16 | $12 |
| Revenue | $7 | $5 | – | $4 |
| % Growth | 61.3% | – | – | – |
| Gross Profit | $5 | $2 | – | $2 |
| % Margin | 64% | 40.9% | – | 38% |
| EBITDA | -$1 | -$6 | – | -$8 |
| % Margin | -12.7% | -121.7% | – | -196.6% |
| Net Income | -$3 | -$6 | – | -$8 |
| % Margin | -42.4% | -134.2% | – | -205.3% |
| EPS Diluted | 0 | 0 | – | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |